Journal article
Primary analysis of a phase II study of metastasis-directed ablative therapy to PSMA ( 18 F-DCFPyL) PET-MR/CT defined oligorecurrent prostate cancer.
Abstract
5553
Authors
Glicksman R; Metser U; Vines D; Chan R; Valliant J; Chung PWM; Gospodarowicz MK; Bayley A; Catton CN; Warde PR
Journal
Journal of Clinical Oncology, Vol. 38, No. 15_suppl, pp. 5553–5553
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2020
DOI
10.1200/jco.2020.38.15_suppl.5553
ISSN
0732-183X